Recruitment to the REACT-GE Study has now ended.
Frequently Asked Questions
& GenOMICC COVID-19 Study
Read our Frequently Asked Questions. These FAQs will be regularly maintained.
If you have any questions not answered on this page, please get in touch with Genomics England on 0808 2819 535 (UK toll-free).
One of their blood samples was sent to a laboratory to prepare it for genomic sequencing by Illumina, our partners at Cambridge University. The remaining samples were sent to a laboratory in London operated by Affinity Biomarkers Labs who processed them and prepare them for sending to other academic and commercial partners in the UK and overseas to carry out analyses for research purposes.
Imperial College and other research institutions both academic and commercial may carry out research using the data and samples provided by the Study, including genetic analysis to identify genes that may predispose people to disease. Participants will never be personally identified to any researcher outside the REACT-GE Study team. The results of any research that is published, whether by Imperial College or anyone else, will never identify a participant.
From time to time we will inform our participants of other research studies that they might be interested in participating in. We would only share a participant's contact details with other researchers if they gave us their consent, so that the researchers can contact them with information about such studies. There is no obligation to take part in such studies.
Yes. We will report to you whether you still have antibodies to SARS-CoV-2, the virus that causes COVID-19. We will provide you with the lab-based test result of your SARS-CoV-2 Antibody Test, which has been carried out for research purposes. It is carried out using an approved test system.
You should receive your results within 4 weeks of attending the assessment centre. If you have not received them after 6 weeks, please check your spam/junk mail folder. if you are unable to find them then please email the REACT study at React.GE.Study@imperial.ac.uk and we will re-send them. If we were unable to obtain blood samples from you when you attended then you will not receive any results.
We will provide you with physical measurements taken and the results of your blood analyses which provide indications of your cholesterol levels and risk of diabetes. These measurements and analyses enable the calculation of a QRISK3 assessment. This tells you to what extent you may be at risk of a heart attack or stroke in the next 10 years. For more information, visit QRISK.org.
You can withdraw from the study at any time without giving reasons. You will have to inform the study team of your wish by phone (0808 2819 535), email (email@example.com) or letter (FAO Service Desk, Genomics England, Queen Mary University of London, Dawson Hall, London, EC1M 6BQ).
We will then send you a Withdrawal from Study Form which has to be signed by you and sent back to the research team at Imperial College.
We will not share any information with your GP. No results will go on your NHS records. We will make available to you the following:
- A report as to whether you still have antibodies to SARS-CoV-2, the virus that causes COVID-19.
- A report with the physical measurements taken and the results of your blood analyses which provide indications of your cholesterol levels and risk of diabetes. These measurements and analyses enable the calculation of a QRISK3 assessment of your likelihood of having a heart attack or stroke in the next 10 years.
You are welcome to discuss these with your GP but you will have to take a copy with you.
To keep up to date with the study you can sign up to our the GenOMICC-Genomics England e-newsletter here.
You will be asked to confirm your subscription to this newsletter by email. We use a third-party provider, MailChimp, to deliver our newsletters. Please read our privacy notice for further information on how we handle your data. You can unsubscribe at any time using the ‘unsubscribe’ link in the emails we send.
What happens to my data once it has been sequenced? Where is it stored?
Once our sequencing partner Illumina has sequenced patients’ whole genomes, they send back the sequences to Genomics England. We will then strip identity labels from it and the de-identified genomic data will be stored in Genomics England’s secure database, the National Genomic Research Library. Only validated health researchers with express permission are allowed to access the raw data.
How will my data be protected and remain confidential?
Our priority is always to ensure that the data of all participants is protected. Any data that researchers can access has been de-identified. This data cannot be removed or copied by researchers. We are committed to full transparency about the use of people’s data. Read our privacy notice for more information.